[18F]F-RESCA-RT4

N/A

Report date: 2025/12/09 20:00:11
NME

Base Information

Drug Name[18F]F-RESCA-RT4
Drug Alias Name[18F]RT4
ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionTumor-associated calcium signal transducer 2 binders
TargetsTumor-associated calcium signal transducer 2
Therapy Area/IndicationsSolid tumoursUrinary Bladder NeoplasmsProstatic Neoplasms +[13] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesRenji Hospital Affiliated To Shanghai Jiaotong University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesRenji Hospital Affiliated To Shanghai Jiaotong University School Of Medicine
Inactive CompaniesN/A
Active IndicationsSolid tumoursUrinary Bladder NeoplasmsProstatic Neoplasms +[13] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A